Kneat to Present at The Emerging Growth Conference on September 24, 2025
Kneat (OTCQX:KSIOF), a leader in digitizing validation and quality processes for life sciences, will present at the Emerging Growth Conference on September 24, 2025, from 9:40 AM to 10:10 AM ET. CEO and co-founder Eddie Ryan will provide a company overview and discuss recent business progress.
The interactive online event will allow shareholders and investors to engage directly with management through a Q&A session. Kneat's flagship platform, Kneat Gx, enables life science companies to digitize validation processes, reduce risk, and accelerate product time-to-market. The company serves many leading global pharmaceutical companies.
Kneat (OTCQX:KSIOF), leader nella digitalizzazione dei processi di convalida e qualità nelle scienze della vita, parteciperà al Emerging Growth Conference il 24 settembre 2025, dalle 9:40 alle 10:10 ET. Il CEO e cofondatore Eddie Ryan offrirà una panoramica dell'azienda e discuterà dei progressi recenti dell'attività.
L'evento online interattivo permetterà agli azionisti e agli investitori di interagire direttamente con il management tramite una sessione di Q&A. La piattaforma di punta di Kneat, Kneat Gx, consente alle aziende delle scienze della vita di digitalizzare i processi di convalida, ridurre i rischi e accelerare il time-to-market dei prodotti. L'azienda serve numerose importanti aziende farmaceutiche globali.
Kneat (OTCQX:KSIOF), líder en la digitalización de procesos de validación y calidad en las ciencias de la vida, presentará en la Emerging Growth Conference el 24 de septiembre de 2025, de 9:40 a. m. a 10:10 a. m. ET. El director ejecutivo y cofundador Eddie Ryan dará una visión general de la empresa y discutirá los avances recientes.
El evento en línea interactivo permitirá a accionistas e inversores interactuar directamente con la dirección a través de una sesión de preguntas y respuestas. La plataforma insignia de Kneat, Kneat Gx, permite a las empresas de ciencias de la vida digitalizar los procesos de validación, reducir riesgos y acelerar el lanzamiento de productos al mercado. La empresa atiende a numerosas compañías farmacéuticas líderes a nivel mundial.
Kneat (OTCQX:KSIOF), 생명과학 분야의 검증 및 품질 프로세스 디지털화 선도기업은 2025년 9월 24일 동부 표준시 9:40~10:10에 열리는 Emerging Growth Conference에 발표 will 합니다. CEO 겸 공동 설립자 Eddie Ryan이 회사 개요를 제공하고 최근 비즈니스 진행 상황을 논의할 예정입니다.
인터랙티브 온라인 이벤트는 주주와 투자자들이 경영진과의 Q&A 세션을 통해 직접 소통할 수 있도록 할 것입니다. Kneat의 주력 플랫폼인 Kneat Gx은 생명과학 기업이 검증 프로세스를 디지털화하고 위험을 줄이며 제품의 시판 속도를 높이도록 해줍니다. 이 회사는 다수의 글로벌 제약사를 대상으로 서비스를 제공합니다.
Kneat (OTCQX:KSIOF), leader dans la numérisation des processus de validation et de qualité pour les sciences de la vie, participera à la Emerging Growth Conference le 24 septembre 2025, de 9h40 à 10h10 ET. Le PDG et co-fondateur Eddie Ryan présentera une vue d’ensemble de l’entreprise et discutera des progrès récents.
L'événement en ligne interactif permettra aux actionnaires et investisseurs d’interagir directement avec la direction lors d’une séance de questions-réponses. La plateforme phare de Kneat, Kneat Gx, permet aux entreprises des sciences de la vie de numériser les processus de validation, de réduire les risques et d’accélérer le time-to-market des produits. L’entreprise dessert de nombreuses grandes sociétés pharmaceutiques mondiales.
Kneat (OTCQX:KSIOF), ein führendes Unternehmen bei der Digitalisierung von Validierungs- und Qualitätsprozessen in den Lebenswissenschaften, wird bei der Emerging Growth Conference am 24. September 2025, von 9:40 bis 10:10 Uhr ET präsentieren. CEO und Mitbegründer Eddie Ryan wird einen Überblick über das Unternehmen geben und die jüngsten Geschäftsentwicklungen erörtern.
Das interaktive Online-Event ermöglicht es Aktionären und Investoren, direkt mit dem Management in einer Q&A-Sitzung zu interagieren. Kneats Flaggschiff-Plattform Kneat Gx ermöglicht es Lebenswissenschaftsunternehmen, Validierungsprozesse zu digitalisieren, Risiken zu verringern und die Markteinführungszeit ihrer Produkte zu verkürzen. Das Unternehmen bedient viele führende globale Pharmaunternehmen.
Kneat (OTCQX:KSIOF)، رائدة في رقمنة عمليات التحقق والجودة لعلوم الحياة، ستشارك في مؤتمر Emerging Growth Conference في 24 سبتمبر 2025، من 9:40 صباحاً حتى 10:10 صباحاً بالتوقيت الشرقي. سيقدّم الرئيس التنفيذي والمؤسس المشارك إدي رايان عرضاً عاماً عن الشركة ويناقش التقدمات التجارية الحديثة.
الحدث التفاعلي عبر الإنترنت سيسمح للمساهمين والمستثمرين بالتفاعل مباشرة مع الإدارة من خلال جلسة أسئلة وأجوبة. منصة Kneat الرائدة، Kneat Gx، تسمح لشركات علوم الحياة برقمنة عمليات التحقق، وتقليل المخاطر، وتسريع وقت الدخول إلى السوق. تخدم الشركة العديد من شركات الأدوية العالمية الرائدة.
Kneat (OTCQX:KSIOF)，在生命科学领域的验证与质量流程数字化方面处于领先地位，将在 2025年9月24日，东部时间上午9:40–10:10 参加新兴增长大会。首席执行官兼联合创始人 Eddie Ryan 将提供公司概览并讨论最近的业务进展。
互动在线活动 将允许股东和投资者通过问答环节与管理层直接互动。Kneat 的旗舰平台 Kneat Gx 使生命科学公司能够数字化验证流程、降低风险并加速产品上市时间。该公司为多家全球领先的制药公司提供服务。
- None.
- None.
Kneat invites investors to real-time, interactive engagement with CEO Eddie Ryan
Limerick, Ireland--(Newsfile Corp. - September 16, 2025) - kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that it will be presenting at the Emerging Growth Conference on September 24, 2025.
This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with Kneat's Chief Executive Officer and co-founder, Eddie Ryan, in real time.
Eddie Ryan Portrait
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11876/266674_eddieryan.jpg
Mr. Ryan will give an overview of Kneat, a fast-growing TSX-listed software company and the progress the business has made in recent quarters. Kneat makes easy-to-use, no-code, highly configurable software that allows life science companies to digitize all their validation processes, their way.
After the presentation, Mr. Ryan will invite participants to ask questions. Questions may be submitted in advance to Questions@EmergingGrowth.com or during the event.
Kneat will present at 9:40 AM ET – 10:10 AM ET on Wednesday, September 24, 2025.
Interested parties can register for the live conference via the following link:
An archived webcast will also be made available after the event.
A leader in its space, Kneat's intelligent, data-centric documentation workflow process platform, Kneat Gx, replaces paper with real-time data capture, enabling companies to reduce risk while getting products to market faster. Since winning its first customer ten years ago, Kneat has helped to revolutionize the speed, precision, transparency and intelligence of validation in the Life Sciences sector. Today, Kneat's platform is used by most of the world's leading Life Sciences companies, including most of the world's largest pharmaceutical companies, to validate their quality processes digitally.
About Kneat
Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. compliance standard. Independent customer studies have shown Kneat Gx to reduce labor hours associated with validation documentation by more than
For further information:
Katie Keita, Kneat Investor Relations
P: + 1 902-450-2660
E: investors@kneat.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/266674
FAQ
When is Kneat (KSIOF) presenting at the Emerging Growth Conference?
Who will be presenting for Kneat at the Emerging Growth Conference?
How can investors participate in Kneat's Emerging Growth Conference presentation?
What is Kneat's main product offering?
Will there be a recording of Kneat's presentation available?
